Brand & Generic Names
Basic Information
- Habit forming? No
- Prescription needed? Yes
- Available as generic? No
- Drug class: Antiviral
Uses
- Treats human immunodeficiency virus (HIV).
- Treats acquired immunideficiency syndrome (AIDS).
Dosage & Usage Information
How to take:
Tablets--Chew or manually crush tablet. If crumble tablet, mix with at least 1 ounce of water and swallow immediately.
Buffered didanosine for oral solution--Dissolve packet contents in 4 ounces of water.
When to take:
At the same times each day, according to instructions on prescription
label.
If you forget a dose:
Take as soon as yoou remember up to 2 hours late. If more than 2
hours, wait for next scheduled dose (don't double this dose).
What drug does:
Suppresses replication of human immunodeficiency virus.
Time lapse before drug works:
90 minutes.
Don't take with:
See Interaction section and consult doctor.
Overdose
SYMPTOMS:
Seizures.
WHAT TO DO:
- Dial 911 (emergency) or O (operator) for an ambulance or medical
help. Then give first aid immediately.
- See EMERGENCY information.
Possible Adverse Reactions or Side Effects
Life-threatening:
Seizures. Seek emergency treatment immediately.
Common:
- Tingling, numbness
and burning in the feet
and ankles.
- Headache, anxiety,
restlessness, digestive
disturbances, diarrhea.
Infrequent:
Unusual tiredness and
weakness, fever, chills,
sore throat, unusual
bleeding or bruising,
yellow skin and eyes,
skin rash.
Rare:
Warnings & Precautions
Don't take if:
You are allergic to didanosine.
Before you start, consult your doctor:
- If you are an alcoholic.
- If you have hypertriglyceridemia or pancreatitis.
- If you have any condition requiring sodium restriction.
- If you have liver disease, impaired liver function or peripheral
neuropathy.
- If you have gout.
Over age 60:
No special problems expected.
Pregnancy:
Unknown effect. Consult doctor.
Breast-feeding:
Unknown effect. Consult doctor.
Infants & children:
May cause depigmentation of the retina. Children should have eye exams every 3-6 months to check for vision changes.
Prolonged use:
Talk with your doctor about the need for follow-up medical examination or laboratory studies to check blood serum and uric acid levels.
Skin & sunlight:
No special problems expected.
Driving, piloting or hazardous work:
Don't drive or pilot aircraft until you learn how medicine affects
you. Don't work around dangerous machinery. Don't climb ladders or
work in high places. Danger increases if you drink alcohol or take
medicine affecting alertness and reflexes, such as antihistamines,
tranquilizers, sedatives, pain medicines, narcotics and mind-altering
drugs.
Discontinuing:
Don't discontinue without consulting doctor. Dose may require gradual
reduction if you have taken drug for a long time. Doses of other
drugs may require adjustment.
Others:
- Advise any doctor or dentist whom you consult that you take this
medicine.
- Avoid sexual intercourse or use condoms to help prevent the
transmission of HIV.
- Don't share needles or injectable equipment with other persons.
- The drug zidovudine should be used as the initial treatment for HIV
infection since there are no controlled studies as yet on the
effectiveness of didanosine in prolonging survival or decreasing the
incidence of opportunistic infections.
Possible Interaction with Other Drugs
GENERIC NAME |
COMBINED EFFECT |
| |
------------------------- |
----------------------- |
Asparaginase |
Increased risk of pancreatitis. |
Azathioprine |
Increased risk of pancreatitis. |
Chloramphenicol |
Increased risk of peripheral neuropathy. |
Dapsone |
Increased risk of peripheral neuropathy. |
|
Reduced absorption of both drugs. |
Diuretics, thiazide* |
Increased risk of pancreatitis. |
Estrogens* |
Increased risk of pancreatitis. |
Ethambutol |
Increased risk of peripheral neuropathy. |
Ethionamide |
Increased risk of peripheral neuropathy. |
Fluoroquinolone |
Reduced antibiotic effect. |
| |
| |
Furosemide |
Increased risk of pancreatitis. |
Hydralazine |
Increased risk of peripheral neuropathy. |
Isoniazid |
Increased risk of peripheral neuropathy. |
Itraconazole |
Decreased absorption of itraconazole. |
Ketoconazole |
Reduced absorption of both drugs. |
|
Increased risk of pancreatitis. |
Lithium |
Increased risk of peripheral neuropathy. |
Methyldopa |
Increased risk of pancreatitis. |
Metronidazole |
Increased risk of peripheral neuropathy. |
Nitrofurantoin |
Increased risk of pancreatitis and |
|
peripheral neuropathy. |
Phenytoin |
Increased risk of peripheral neuropathy. |
Sulfonamides* |
Increased risk of pancreatitis. |
Sulindac |
Increased risk of pancreatitis. |
Tetracyclines |
Decreased antibiotic effect. |
Valproic acid |
Increased risk of pancreatitis. |
Vincristine |
Increased risk of peripheral neuropathy. |
Possible Interaction with Other Substances
INTERACTS WITH |
COMBINED EFFECT |
--------------- |
--------------- |
Alcohol: |
Increased chance of pancreatitis or |
|
peripheral neuropathy. |
| |
Beverages: |
No proven problems. |
| |
Cocaine: |
No proven problems. |
| |
Foods: |
No proven problems. |
| |
Marijuana: |
No proven problems. |
| |
Tobacco: |
No proven problems. |
|